Exercise Cardiomyopathy
|
|
- Flora Cole
- 5 years ago
- Views:
Transcription
1 Exercise Cardiomyopathy Aaron L. Baggish MD, F.A.C.C., F.A.C.S.M. Cardiovascular Performance Program Division of Cardiology Massachusetts General Hospital Boston, MA
2 Conflicts: None Athletic Affiliations: Funding Sources: National Institutes of Health American Heart Association American Society of Echocardiography Department of Defense National Football League Player s Association
3 A History of Our Pastimes 1940 s It wakes a sleepy man up. It sharpens the brain. It widens the smile. It quickens the steps It heightens the jump. Yes, it is the elixir of life JUST ASK YOUR DOCTOR
4 A History of Our Pastimes
5 A History of Our Pastimes 1960 s Free Love. Sex Therapy
6 A History of Our Pastimes
7 A History of Our Pastimes 2000 s
8 A History of Our Pastimes Running can take a toll on the heart that essentially eliminates the benefits of exercise. Running too far, too fast and for too many years may speed one s progress toward the finish line of life, concludes an editorial to be published next month in the British journal Heart.
9 A History of Our Pastimes What do you tell this poor chap who lies in bed and wonders if marathons and triathlons are speeding him toward an early demise? What does this chap tell the throngs of endurance athletes he works with to do now that running is bad for you?
10 Too much exercise? Is exercise destined to go the way tobacco use and liberal sexuality? Can too much exercise over too much time hurt your heart (and affect morbidity and mortality) and if so, what does this pathology look like?
11 The Athlete in CV Medicine Where do they come from and why? The Athlete Sudden Death Asymptomatic Symptomatic Athlete s Heart Vs. Pathology Syncope Arrhythmias ASHD HTN Stamina
12 Too much exercise? 1.) Atrial Fibrillation - YES 2.) Exercise Cardiomyopathy - MAYBE 3.) Coronary Artery Disease - UNLIKELY
13 Atrial Fibrillation
14 Atrial Fibrillation 1 st Author Reference Subjects Primary Finding Karjalainen BMJ 1998 Runners (n=100) 5.5 ( ) Mont EHJ 2002 Endurance (n=70) 71% with lone AF Elosua Int J Card 2006 Endurance (n=51) 2.87 ( ) Heidbuchel Int J Card 2006 Endurance (n=53) 1.81 ( ) Molina Europace 2008 Runnners (n=39) 8.8 ( ) Baldesberger EHJ 2008 Cyclist (n=67) 10% AF in athletes Mont Europace 2008 Endurance (n=48) 7.31 ( ) Aizer Am J Card 2009 PHS Database (n=16,921) 1.20 with 7 days/week ex.* Claessen Heart 2011 Non-sel. Flutter RFA (n=58) Sportsmen 50% of Lone Afl pop. Andersen EHJ 2013 Nordic Skiers (n=52,755) 1.29 ( )*
15 Atrial Fibrillation Retrospective Vasaloppet (90K) Sweden >50,000 participants >> Dec Assessment of arrhythmia events Race time / # of races > Arrhyth. AF the dominant rhtythm issue
16 Atrial Fibrillation Coronary Artery Disease MECHANISM of ATHLETIC AF - LA Dilation / Remodeling - Persistent vagotonia - Sympathetic Surges - Intermit. LA Hypertension - Chronic Inflammation - Genes - ETOH - Caffeine - Psychological Stress
17 Too much exercise? 1.) Atrial Fibrillation - YES 2.) Exercise Cardiomyopathy - MAYBE 3.) Coronary Artery Disease - UNLIKELY
18 Exercise CMP Harvard Athlete Initiative
19 Exercise CMP Am J Physiol Heart Circ Physiol 2008 LV Systolic Strain Changes with Rowing Training (n=20) AS AL AS A AS A MS ML S L S L BS BL I P I P (< -2) (-2 to 2) (2 to 4) (4 to 6) (> 6) (< -2) (-2 to 2) (2 to 4) (4 to 6) (> 6) (< -2) (-2 to 2) (2 to 4) (4 to 6) (> 6) Longitudinal ~ 20-25% Radial ~ 50-60% Circumferential ~ 20-25% Normal to Supranormal Strain.Focal Septal Dysfunction??
20 Exercise CMP The Ventricular Interdependence of Physiologic Remodeling Am J Physiol Heart Circ Physiol 2008;295:1109
21 Exercise CMP Whyte et al. JAP 2011 LaGerche et al. EHJ 2011
22 Exercise CMP 40 trained (>10 h of intense training / week) athletes Competitive, top 25% finish recent endurance event No cardiac symptoms of traditional risk factors No inducible ischemia on stress echo MRI/echo/biochem. At 3 time points (pre-finish-6 to 11 d)
23 Exercise CMP
24 Too much exercise? 1.) Atrial Fibrillation - YES 2.) Exercise Cardiomyopathy - MAYBE 3.) Coronary Artery Disease - UNLIKELY
25 CV Risk Factors with Exercise NEJM 2002 JAMA 1985 Circulation 2007 JAMA 2003
26 CAD 108 M (>50 y.) At least 5 marathons
27 CAD Middle-aged runners (59 y.) (n=50) >25 Consecutive TCM s No training history No race history No physiology
28 CAD Interpretation Options: 1.) Exercise (rec. marathon training) drives athero. 2.) CAD findings driven by established and studied risk factors.underappreciated in these studies 3.) CAD findings driven by overlooked, non-running risk factors
29 CAD Do you really think it was the running that caused these men s coronary disease??
30 CAD Missing Risk Issues: 1.) Diet (Fit vs. Healthy) 2.) Care-free 20 s-30 s 3.) Family Genes Without controlling for these, can we say anything about causality?
31 Endurance Athletes.People Too
32 Clinical Implications and Future Work CAD A. Fib Toxic Exposure CMP
33 Clinical Implications and Future Work 6 Rules of Common Sense for the clinic 1. Aggressive CVD risk factor management 2. Plan for Annual Periodicity 3. Prioritize Warm-ups & Cool Downs 4. Practice Careful Event Preparation 5. Respect a Virus 6. Listen to Warning Signs
34 Thank You!
Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None
Athlete's Heart vs. Cardiac Pathology Clinical Approaches Echo Florida 2012 Aaron L. Baggish MD Cardiovascular Performance Program Cardiac Ultrasound Laboratory Division of Cardiology Massachusetts General
More informationThe Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University
The Athlete s Heart Critical Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution)
More informationApril 22, 2017 Abraham Rothman, MD
April 22, 2017 Abraham Rothman, MD University of Nevada School of Medicine } Definitions } Adults } Children } Heart beats } Children and adolescents who want to participate in intensive exercise. } Just
More informationEndurance Exercise and Cardiovascular Health
Endurance Exercise and Cardiovascular Health Professor Sanjay Sharma St George s University of London St George s Hospital NHS Trust sasharma@sgul.ac.uk @SSharmacardio Conflicts/Disclosures: None Objectives
More informationAthlete s Heart vs. Cardiomyopathy
Athlete s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets
More informationJonathan Kim MD, FACC
Jonathan Kim MD, FACC Assistant Professor, Division of Cardiology, Emory University Adjunct Assistant Professor, School of Applied Physiology, Georgia Tech Team Cardiologist, Sports Medicine, Emory University
More informationNovel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD
Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD Ospedale San Pietro Fatebenefratelli Rome, Italy Differential
More informationAthlete s Heart vs. Cardiomyopathy
Athlete s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets
More informationThe Female Athlete. Malcolm Legget
The Female Athlete Malcolm Legget MCQ Is complete LBBB or RBBB a training related ECG abnormality in women 1. Yes 2. No 3. Sometimes Participation in Sport Female sports participation increasing. Paris
More informationEndurance training and cardiac arrhythmias
Endurance training and cardiac arrhythmias Myocardial and autonomic alterations under endurance training Federico Lombardi, MD, FESC Cardiologia, Osp. San Paolo D.M.C.O. University of Milan Milan, Italy
More informationThe Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University
The Athlete s Heart Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution) for Core
More informationΑΡΡΥΘΜΙΟΓΟΝΟΣ ΜΥΟΚΑΡΔΙΟΠΑΘΕΙΑ ΤΗΣ ΔΕΞΙΑΣ ΚΟΙΛΙΑΣ ΣΧΕΤΙΖΟΜΕΝΗ ΜΕ ΤΗΝ ΑΣΚΗΣΗ ΓΕΩΡΓΙΟΣ ΣΤΑΥΡΟΠΟΥΛΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Γ.Ν.ΒΕΡΟΙΑΣ
ΑΡΡΥΘΜΙΟΓΟΝΟΣ ΜΥΟΚΑΡΔΙΟΠΑΘΕΙΑ ΤΗΣ ΔΕΞΙΑΣ ΚΟΙΛΙΑΣ ΣΧΕΤΙΖΟΜΕΝΗ ΜΕ ΤΗΝ ΑΣΚΗΣΗ ΓΕΩΡΓΙΟΣ ΣΤΑΥΡΟΠΟΥΛΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Γ.Ν.ΒΕΡΟΙΑΣ Increased Adherence In High Endurance Competitions In An Sedentary Society : A Paradox
More informationAthletes with cardiac disease; dead and buried or chance for resurrection?
Athletes with cardiac disease; dead and buried or chance for resurrection? EuroPRevent 2011 Geneva F. Carré University Rennes 1-Pontchaillou Hospital Inserm U642, Rennes - F-35000 Risk of physical activity
More informationSudden Cardiac Death in Sports: Causes and Current Screening Recommendations
Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and
More informationIndex. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A AEDs. See Automated external defibrillators (AEDs) AF. See Atrial fibrillation (AF) Age as factor in SD in marathon runners, 45 Antiarrhythmic
More informationPre-participation screening is warranted: Pro
Controversies on marathon and beyond Pre-participation screening is warranted: Pro DOMENICO CORRADO, MD, PhD Department of Cardiac, Thoracic and Vascular Sciences University of Padova, Italy domenico.corrado@unipd.it
More informationEcho Evaluation of the Heart of an Athlete
Echo Evaluation of the Heart of an Athlete 18 th SA Heart Congress, 2017 Johannesburg, South Africa November 9-12, 2017 Naser Ammash. MD Professor of Medicine Practice Chair, Cardiovascular Department
More informationEndurance sports and sudden cardiac death
Symposium: Endurance training and ventricular arrhythmias Endurance sports and sudden cardiac death DOMENICO CORRADO, MD, PhD Department of Cardiac, Thoracic and Vascular Sciences University of Padova,
More informationExcess exercise 'hurts the heart' and cause dangerous long-term harm, say scientists Mail... Page 1 of 10
Excess exercise 'hurts the heart' and cause dangerous long-term harm, say scientists Mail... Page 1 of 10 Click here to print Excess exercise 'hurts the heart' and cause dangerous long-term harm, say scientists
More informationWhen Should I Order a Stress Test or an Echocardiogram
When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular
More informationHistorical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries
Clinical Exercise Testing in the Athlete The athlete s heart Sudden cardiac death in athletes Screening athletes for cardiovascular disease Historical Notes: Giovanni Lancisi (father of cardiology), 17
More informationOutline. Many Health Benefits of exercise for all ages. Over age 35 years- drawn to endurance exercise. Risks of exercise
Outline Sports Cardiology In Endurance Athletes AKOMA CME Conference 5-1-14 Anchorage AK Christine E. Lawless, MD, MBA, FACC, FACSM, CAQSM Founder, ACC Sports and Exercise Cardiology Council President-Sports
More informationSudden Cardiac Arrest in Athletes Capital City Sports Summit June 7, 2012
Sudden Cardiac Arrest in Athletes Capital City Sports Summit June 7, 2012 John Katopodis, MD, FACC Southern Medical Group Cardiology Tallahassee, Florida Scope of the Problem Relating to Screening and
More informationScope
Scope Global burden of heart disease Physical activity trends Overview of CR A happy problem Principles of CR in athletes Classification of sport Existing guidelines Exercise testing & prescription HIIT
More informationEVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington
EVALUATION OF THE 12 ATHLETE Karen Stout, MD Professor, Medicine and Pediatrics University of Washington NO DISCLOSURES OUTLINE Why evaluate athletes? What s the problem? What evaluation should be done?
More informationI have financial relationships to disclose Consultant for: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi, Merck, Menarin Research support
I have financial relationships to disclose Consultant for: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi, Merck, Menarin Research support from: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi,
More informationThursday, June 20 Session I: Sports Cardiology 101: The Basics of Cardiopulmonary Testing and Athletic Imaging Moderators:
Thursday, June 20 Session I: Sports Cardiology 101: The Basics of Cardiopulmonary Testing and Athletic Imaging 9:00 a.m. Registration OPTIONAL Pre-conference 1: CPET 101 (Limited participation; Additional
More informationHypertrophic Cardiomyopathy: beyond gradient and wall thickness
Hypertrophic Cardiomyopathy: beyond gradient and wall thickness Michael H. Picard, M.D. Massachusetts General Hospital Harvard Medical School no disclosures special thanks to A. Baggish 1 Hypertrophic
More informationImaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD
Imaging in Heart Failure: A Multimodality Approach Thomas Ryan, MD Heart Failure HFrEF HFpEF EF50% Lifetime risk 20% Prevalence 6M Americans Societal costs - $30B 50% 5-year survival 1 Systolic
More informationCardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement
Cardiomyopathy Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Nebraska Home Office Life Underwriters Association March 20, 2018 1 Cardiomyopathy A myocardial disorder in which
More informationThe 2014 Mayo Approach to the Management of HCM and Non-Compaction
The 2014 Mayo Approach to the Management of HCM and Non-Compaction R A Nishimura MD MACC MACP Judd and Mary Morris Leighton Professor Mayo Clinic No disclosures or conflict of interest CP1288794-1 Let
More informationKey wards: PR Interval, QT interval, bradycardia.
bü z ÇtÄ TÜà väx : A Pilot Study Eman Abdo Elaziz Ahmed 1 and Amal Mahmoud Saied 2 Abstract Background: Sudden deaths of young competitive athletes are tragic events that continue to have a considerable
More informationThe Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD
The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD Cardiovascular Performance Program, MGH Assistant Professor of Medicine, Harvard Medical School Outline Athlete s Heart
More informationProgram Schedule Cardiology Update: The Heart of the Matter 2019
Program Schedule Cardiology Update: The Heart of the Matter 2019 Thursday, August 1, 2019 12:50 p.m. Registration and Exhibits 1:50 p.m. Welcome Announcements SESSION 1 2:00 p.m. Long QT Syndrome and Exercise:
More informationAtrial Fibrillation and You
Atrial Fibrillation and You Dr Matthew Fay General Practitioner AFA Medical Advisory Committee Member NHS-Improvement Clinical Lead AF & U Dr Matthew Fay General Practitioner AFA Medical Advisory Committee
More informationEKG screening in athletics
Use of PPE EKG screening in athletics Stefan Montgomery MD, ATC 4/27/18 The overall role of the preparticipation physical evaluation (PPE) is to evaluate the health of the athlete to optimize safe sports
More informationPotential recommendations for CT coronary angiography in athletes
Potential recommendations for CT coronary angiography in athletes B.K. Velthuis Dept. of Radiology UMC Utrecht, the Netherlands EuroPRevent 15 April 2011 Declaration of interest Philips Medical Systems
More informationInvestigating senior athletes for cardiovascular disease. Antonio Pelliccia, MD
Investigating senior athletes for cardiovascular disease Antonio Pelliccia, MD www.antoniopelliccia.it Middle-aged, male marathon runner LAD LAD RC Replacement fibrosis Non-obstructive fibrous plaque
More informationATRIAL FIBRILLATION: IS IT REALLY TYPE 2 DIABETES MASQUERADING AS CARDIAC MISFORTUNE?
ATRIAL FIBRILLATION: IS IT REALLY TYPE 2 DIABETES MASQUERADING AS CARDIAC MISFORTUNE? ROBERT M PEPPER, DO, FAAFP ASSISTANT DEAN OF PRE DOCTORAL CLINICAL SCIENCES WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE
More informationThe First Large-scale Public Cardiac Screening to Protect Athletes Health in Hong Kong (CASPAR)
The First Large-scale Public Cardiac Screening to Protect Athletes Health in Hong Kong Pre-participation Cardiovascular Screening Program for First-Time MArathon Runners (CASPAR) Speakers Professor Hung-Fat
More informationCardiac hypertrophy : differentiating disease from athlete
Cardiac hypertrophy : differentiating disease from athlete Ario Soeryo Kuncoro, MD, Cardiologist Echocardiography Division, National Cardiovascular Centre Harapan Kita-Jakarta Departement of Cardiology
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationSudden Cardiac Death in Youth Athletes. Dublin City Schools Athletic Health Care
Sudden Cardiac Death in Youth Athletes Dublin City Schools Athletic Health Care Sudden Cardiac Death What is sudden cardiac death in the young athlete? Sudden cardiac death is the result of an unexpected
More informationESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy
ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy Task force on the management of CVD during pregnancy of the ESC Chair: Vera Regitz-Zagrosek, Charite, Berlin None DECLARATION
More informationAtrial Cardiomyopathy is it relevant?
Atrial Cardiomyopathy is it relevant? Dr Carl Shakespeare MD FRCP FACC FESC Consultant Cardiologist Relevance Progressive nature of AF Implications for RF Targeting Risk Factors CHADS vasc scoring? Could
More informationThe Management of Hypertrophic Cardiomyopathy
The Management of Hypertrophic Cardiomyopathy Evidence and Uncertainties Banff 2013 3058464-0 Management of HCM Key Elements Screen 1 relatives for HCM Serial Echo Genetic testing Assess risk for and prevent
More informationDRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica
Corso Multidisciplinare di Aggiornamento La Sindrome delle Apnee Notturne: una sfida diagnostico terapeutica DRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica FRANCESCO PERNA, MD, PhD Laboratorio
More informationEchocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016
Echocardiographic Evaluation of the Cardiomyopathies Stephanie Coulter, MD, FACC, FASE April, 2016 Cardiomyopathies (CMP) primary disease intrinsic to cardiac muscle Dilated CMP Hypertrophic CMP Infiltrative
More information» A new drug s trial
» A new drug s trial A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause
More informationManaging Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology
Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation
More informationExercise Associated collapse. ACSM Team Physician Course Part II 2/4/2017 Jerrad Zimmerman MD
Exercise Associated collapse ACSM Team Physician Course Part II 2/4/2017 Jerrad Zimmerman MD Exercise Associated Collapse Characterized by collapse after completion of an intense exercise event in the
More informationGlobal left ventricular circumferential strain is a marker for both systolic and diastolic myocardial function
Global left ventricular circumferential strain is a marker for both systolic and diastolic myocardial function Toshinari Onishi 1, Samir K. Saha 2, Daniel Ludwig 1, Erik B. Schelbert 1, David Schwartzman
More informationEchocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction
Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction October 4, 2014 James S. Lee, M.D., F.A.C.C. Associates in Cardiology, P.A. Silver Spring, M.D. Disclosures Financial none
More informationDiabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
More informationAF#in#pa(ents#with#CAD# Is#dronedarone#a#good#choice?!
AF#in#pa(ents#with#CAD# Is#dronedarone#a#good#choice?! DRUG#PROPHYLAXIS#OF#AF:# FOCUS#ON#DRONEDARONE# Friday#16C10C2015# Harry%JGM%Crijns% Maastricht,%The%Netherlands% Disclosures Harry Crijns - research
More informationRisk Factors for Sudden cardiac Death
Risk Factors for Sudden cardiac Death A. Arenal Arrhythmias in competitive sports Disclosure Conflict of interest Advisory board: Medtronic, Boston Scientific Research grants: Medtronic, Boston Scientific,
More informationIS ATRIAL FIBRILLATION THE NEXT TYPE 2 DIABETES?
IS ATRIAL FIBRILLATION THE NEXT TYPE 2 DIABETES? ROBERT M PEPPER, DO, FAAFP ASSISTANT DEAN PREDOCTORAL CLINICAL EDUCATION WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE IS ATRIAL FIBRILLATION THE NEXT TYPE
More informationIschemic Heart Disease and Sport
Ischemic Heart Disease and Sport Dr Benoît GERARDIN - Clinique Ambroise Paré, Neuilly Hôpital de Neuilly - RACcE (GRCI). - amateur sportsman Journées Européennes de la SFC - Janvier 2014 - Introduction
More informationHFpEF. April 26, 2018
HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes
More informationCARDIAC BENEFICIAL EFFECTS AND ADAPTATIONS IN ATHLETES
ARISTOTLE UNIVERSITY OF THESSALONIKI, GREECE SPORTS MEDICINE LABORATORY DIRECTOR: PROF. A. DELIGIANNIS CARDIAC BENEFICIAL EFFECTS AND ADAPTATIONS IN ATHLETES ASTERIOS DELIGIANNIS CARDIOLOGIST PROFESSOR
More informationNatural History and Echo Evaluation of Aortic Stenosis
Natural History and Echo Evaluation of Aortic Stenosis Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM AORTIC STENOSIS First valvular disease
More informationProfessor Sanjay Sharma St George s University of London
How to Evaluate an Athlete of Afro- Caribbean Origin. Professor Sanjay Sharma St George s University of London Background: Causes of SCD in Sport Young competitive athlete Personal and family history Physical
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationTachycardias II. Štěpán Havránek
Tachycardias II Štěpán Havránek Summary 1) Supraventricular (supraventricular rhythms) Atrial fibrillation and flutter Atrial ectopic tachycardia / extrabeats AV nodal reentrant a AV reentrant tachycardia
More informationSupraventricular Tachycardia: From Fetus to Adult. Mohamed Hamdan, MD
Supraventricular Tachycardia: From Fetus to Adult Mohamed Hamdan, MD Learning Objectives Define type of SVT by age Describe clinical approach Describe prenatal and postnatal management of SVT 2 SVT Across
More informationRight ventricular adaptation in endurance athletes. António Freitas. No conflict of interest
The role of echocardiography in sports cardiology Right ventricular adaptation in endurance athletes. António Freitas Cardiology Department - Fernando Fonseca Hospital Lisbon Sports Medicine Centre - Lisbon
More informationManagement of Arrhythmias The General Practitioners role
Management of Arrhythmias The General Practitioners role Rohan Gunawardena MD, FRCP, FCCP, FACC Consultant Cardiac Electrophysiologist National Hospital of Sri Lanka Arrhythmias not common Palpitations
More informationThe Dangers of Too Little Vs. Too Much Exercise. Exercise and Health
The Dangers of Too Little Vs. Too Much Exercise Robert E. Sallis, MD, FAAFP, FACSM Co-Director, Sports Medicine Fellowship Kaiser Permanente; Fontana, CA Chair, Exercise Is Medicine Advisory Board Clinical
More informationDevices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine
Devices and Other Non- Pharmacologic Therapy in CHF Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine Disclosure None University of Miami vs. OSU Renegade Miami football
More informationSudden Cardiac Death
Sudden Cardiac Death Exercise and Risk SCD and AMI 6-17 times more likely to occur during physical activity Still very low risk overall SCD overall occurs around once per 1.5 million episodes of vigorous
More informationSleep and Heart Health: Consequences of OSA
Sleep and Heart Health: Consequences of OSA Michelle Zetoony, DO, FCCP, FACOI Sleep Medicine Specialist Board Certified Pulmonary, Critical Care, Sleep and Internal Medicine 2014 Objectives Explain the
More informationHow to Read an Athlete s ECG. Sanjay Sharma BSc (Hons), MD, FRCP, FESC
How to Read an Athlete s ECG Sanjay Sharma BSc (Hons), MD, FRCP, FESC Athlete s EKG Vagotonia Sinus bradycardia Sinus arrhythmia First degree AVB ST-elevation Tall T waves Increased chamber size Left ventricular
More informationEVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES
EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES UNIT OF INHERITED CV DISEASES HEART CENTER OF THE YOUNG AND ATHLETES A DPT OF CARDIOLOGY UNIVERSITY OF ATHENS EVALUATION OF ELECTROCARDIOGRAPHIC
More informationNON-INVASIVE TREATMENT OPTIONS IN HYPERTROPHIC CARDIOMYOPATHY
NON-INVASIVE TREATMENT OPTIONS IN HYPERTROPHIC CARDIOMYOPATHY SGK, 2015 Christiane Gruner University Heart Center, Zurich Department of Cardiology NONINVASIVE TREATMENT OPTIONS: TOPICS 1. LVOT obstruction
More informationPolypharmacy - arrhythmic risks in patients with heart failure
Influencing sudden cardiac death by pharmacotherapy Polypharmacy - arrhythmic risks in patients with heart failure Professor Dan Atar Head, Dept. of Cardiology Oslo University Hospital Ullevål Norway 27.8.2012
More informationCLINICAL RESEARCH ON CARDIOVASCULAR ALTERATION ON 86 S PROFESSIONAL ATHLETES IN IRAN
CLINICAL RESEARCH ON CARDIOVASCULAR ALTERATION ON 86 S PROFESSIONAL ATHLETES IN IRAN Lotfali Pourkazemi 1 * and Roghieh Razeghi Jadid 2 1 Sports Medicine Federation of Iran 2 Department of Herbal Sciences,
More informationSleep Apnea and Heart Failure
Sleep Apnea and Heart Failure Micha T. Maeder, MD Cardiology Division Kantonsspital St. Gallen Switzerland micha.maeder@kssg.ch Sleep Disordered Breathing (SDB) in HFrEF 700 HFrEF patients (LVEF
More informationTachycardia-induced heart failure - Does it exist?
Tachycardia-induced heart failure - Does it exist? PD Dr Etienne Delacrétaz Clinique Cecil et Hôpital de Fribourg SSC Cardiology meeting 2015 Zürich Rapid atrial fibrillation is a common cause of heart
More informationMission Statement for our Arrhythmia Care
Mission Statement for our Arrhythmia Care We are dedicated to provide a compassionate and an outstanding care for patients with cardiac arrhythmias. We will be utilizing the cutting edge and the most advanced
More informationPVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.
PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D. Cardiologist and Electrophysiologist No conflict of interest related to this presentation Objectives 1. PVCs are benign. What is the Evidence?
More informationManagement of new-onset AF: Initial rate control treatment
Geneva Acute Crdiovascular Care Congress 2014 - October 18-20, 2014 Management of new-onset AF: Initial rate control treatment Antonio Raviele, MD, FESC, FHRS ALFA Alliance to Fight Atrial fibrillation,
More informationThe Heart of a Cyclist Insights from Sports Cardiology. Michel Accad, MD February 21, 2018 UCSF Mini Medical School
The Heart of a Cyclist Insights from Sports Cardiology Michel Accad, MD February 21, 2018 UCSF Mini Medical School Lecture outline: WARNING: Not a lecture about how to boost your performance! Preliminary
More informationProgression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro
Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Jerónimo Farré MD, Madrid, ES AF: the kingdom of wishful thinking In AF we
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for
More informationOutcome of pre-participation screening of novice middle-aged long-distance runners
Outcome of preparticipation screening of novice middleaged longdistance runners Philip Aagaard 1 A Sahlén 1, L Bergfeldt 2, F Braunschweig 1 1 Karolinska University Hospital, Dept. of Cardiology, Stockholm
More information«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer
«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer Philippe Pibarot, DVM, PhD, FACC, FAHA, FESC, FASE Canada Research Chair in Valvular Heart Diseases Université LAVAL
More informationRate and Rhythm Control of Atrial Fibrillation
Rate and Rhythm Control of Atrial Fibrillation April 21, 2017 춘계심혈관통합학술대회 Jaemin Shim, MD, PhD Arrhythmia Center Korea University Anam Hospital Treatment of AF Goal Reducing symptoms Preventing complication
More informationCatheter-based mitral valve repair MitraClip System
Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular
More informationConsensus document: Screening and Prevention of Atrial Fibrillation
Consensus document: Screening and Prevention of Atrial Fibrillation Yong-Seog Oh, M.D.,Ph.D. Division of Cardiology, Department of Internal Medicine, Seoul St. Mary s Hospital, College of Medicine, The
More informationSudden Cardiac Death in Athletes
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/heart-matters/sudden-cardiac-death-in-athletes/3984/
More informationSports Cardiology Highlights from EuroPRevent 2012 Dublin
Sports Cardiology Highlights from EuroPRevent 2012 Dublin Hein Heidbuchel Cardiology Arrhythmology, University of Leuven, Belgium Past Chair, A Registered Branch of the ESC Sports Cardiology Highlights
More informationMCOEM Spring Chapter Meeting April 5, Sleep Apnea An Overview with Emphasis on Cardiovascular Correlations Jacques Conaway, MD
MCOEM Spring Chapter Meeting April 5, 2014 Sleep Apnea An Overview with Emphasis on Cardiovascular Correlations Jacques Conaway, MD Case Presentation History of Present Illness 57 year old man with ihh/
More informationMitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France
Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related
More informationDeclaration of conflict of interest. None to declare
Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece
More informationReview of Cardiac Imaging Modalities in the Renal Patient. George Youssef
Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives
More informationAdvanced Echocardiography in the Evaluation of Chemotherapy Patients
Advanced Echocardiography in the Evaluation of Chemotherapy Patients Juan Carlos Plana, MD, FACC, FASE Co-Director, Cardio-Oncology Center Section of Cardiovascular Imaging Department of Cardiovascular
More informationTitle: Left atrium size in former elite athletes
Title: Left atrium size in former elite athletes Short title: exercise and left atrium Authors: Fabian Sanchis-Gomar, MD, PhD, a Nuria Garatachea, PhD, a,b Pilar Catalán, MD, c Marta López, MD, d Alejandro
More informationHeart Failure: The Frequent, Forgotten and often Fatal Complication of Type 2 Diabetes
Heart Failure: The Frequent, Forgotten and often Fatal Complication of Type 2 Diabetes DAVID S. H. BELL CHAIRMAN BELL, DSH. DIABETES CARE(2003)26:2433-41. Speaker s Bureau: AstraZeneca Novo Nordisk Janssen
More informationDIASTOLIC HEART FAILURE
DIASTOLIC HEART FAILURE M Mohsen Ibrahim, MD Alexandria, Proposed Criteria for Diastolic Heart Failure ESC Working Group (EHJ 1998) CHF signs/symptoms EF 45% Hemodynamic or echo evidence of diastolic dysfunction
More information